Oliver P. Peoples - Feb 10, 2023 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC. (YTEN)

Role
President and CEO, Director
Signature
Charles B. Haaser, attorney-in-fact
Stock symbol
YTEN
Transactions as of
Feb 10, 2023
Transactions value $
-$22,610
Form type
4
Date filed
2/14/2023, 03:00 PM
Previous filing
Jan 13, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YTEN Common Stock Tax liability -$22.6K -6.3K -14.12% $3.59* 38.3K Feb 10, 2023 Direct F1
holding YTEN Common Stock 8.85K Feb 10, 2023 By 401(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld in payment of withholding taxes upon partial vesting of RSUs granted 2/10/2022
F2 Shares acquired as Issuer matching contribution under the Yield10 Bioscience, Inc. 401(k) Plan.